• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物所致体重增加的防治

[Prevention and treatment of antipsychotic induced weight gain].

作者信息

Veerman S R T, Cohen D

出版信息

Tijdschr Psychiatr. 2023;65(4):259-265.

PMID:37323046
Abstract

BACKGROUND

Metformin is the most investigated pharmacological treatment of antipsychotics-induced weight gain (AIWG). Based on a systematic literature review, the first guideline for the treatment of AIWG with metformin was recently published.

AIM

To present a step-by-step plan, based on recent literature and clinical experience to monitor, prevent, and treat AIWG.

METHOD

Literature search to give specific advice on the choice of antipsychotic medication, stop, dose reduction or switch of antipsychotic, screening, non-pharmacological and pharmacological interventions to prevent and treat AIWG.

RESULTS

Especially in the first year of antipsychotic treatment timely detection of AIWG through regular monitoring is pivotal. The best way to treat AIWG is to prevent its emergence by choosing an antipsychotic with a favourable metabolic profile. Secondly, by titration of antipsychotic medication to the lowest dose possible. Achieving a healthy lifestyle shows a limited beneficial effect on AIWG. Drug-induced weight loss can be attained by the addition of metformin, topiramate, or aripiprazole. Topiramate and aripiprazole can improve positive and negative residual symptoms of schizophrenia. The evidence on liraglutide is scarce. All augmentation strategies may cause side effects. Besides, in case of nonresponse augmentation therapy should be stopped to prevent unnecessary polypharmacy.

CONCLUSION

In the revision of the Dutch multidisciplinary guideline for schizophrenia, the detection, prevention, and treatment of AIWG deserves more attention.

摘要

背景

二甲双胍是针对抗精神病药物所致体重增加(AIWG)研究最多的药物治疗方法。基于一项系统的文献综述,最近发布了关于使用二甲双胍治疗AIWG的首个指南。

目的

根据近期文献和临床经验,提出一个用于监测、预防和治疗AIWG的分步计划。

方法

进行文献检索,以就抗精神病药物的选择、停用、剂量减少或换药、筛查以及预防和治疗AIWG的非药物和药物干预提供具体建议。

结果

尤其是在抗精神病药物治疗的第一年,通过定期监测及时发现AIWG至关重要。治疗AIWG的最佳方法是通过选择具有良好代谢特征的抗精神病药物来预防其出现。其次,将抗精神病药物滴定至尽可能低的剂量。保持健康的生活方式对AIWG的有益作用有限。添加二甲双胍、托吡酯或阿立哌唑可实现药物性体重减轻。托吡酯和阿立哌唑可改善精神分裂症的阳性和阴性残留症状。关于利拉鲁肽的证据较少。所有增效策略都可能引起副作用。此外,如果无反应,应停止增效治疗以避免不必要的多药联用。

结论

在荷兰精神分裂症多学科指南的修订中,AIWG的检测、预防和治疗值得更多关注。

相似文献

1
[Prevention and treatment of antipsychotic induced weight gain].抗精神病药物所致体重增加的防治
Tijdschr Psychiatr. 2023;65(4):259-265.
2
Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis.精神分裂症中抗精神病药物所致体重增加的药物干预:一项网状Meta分析。
Gen Hosp Psychiatry. 2024 Sep-Oct;90:12-21. doi: 10.1016/j.genhosppsych.2024.06.003. Epub 2024 Jun 11.
3
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial.一项随机、双盲、安慰剂对照、多中心试验的研究方案,旨在治疗抗精神病药引起的体重增加:二甲双胍-抗精神病药使用者生活方式干预(MELIA)试验。
BMC Psychiatry. 2021 Jan 5;21(1):4. doi: 10.1186/s12888-020-02992-4.
4
Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.二甲双胍和托吡酯预防和治疗第二代抗精神病药引起的体重增加的疗效。
Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16.
5
Pharmacological Interventions of Atypical Antipsychotics Induced Weight Gain in the Pediatric Population: A Systemic Review of Current Evidence.儿科人群中典型抗精神病药引起的体重增加的药物干预:当前证据的系统评价。
Child Psychiatry Hum Dev. 2024 Apr;55(2):479-487. doi: 10.1007/s10578-022-01424-6. Epub 2022 Sep 6.
6
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.瘦素基因-2548G/A 多态性与抗精神病药引起的体重增加的关联:CATIE 样本分析及荟萃分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Aug 30;102:109952. doi: 10.1016/j.pnpbp.2020.109952. Epub 2020 Apr 23.
7
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.抗精神病药物所致体重增加与治疗益处之间的复杂关系:一项系统综述及对治疗的启示
Front Neurosci. 2018 Jan 22;11:741. doi: 10.3389/fnins.2017.00741. eCollection 2017.
8
Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology.二甲双胍治疗精神分裂症成人抗精神病药引起的体重增加:使用 GRADE 方法制定的首个循证指南。
Evid Based Ment Health. 2022 Feb;25(1):15-22. doi: 10.1136/ebmental-2021-300291. Epub 2021 Sep 29.
9
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis.抗精神病药引起的体重增加的最新进展:系统评价和荟萃分析。
Expert Opin Drug Saf. 2020 Mar;19(3):295-314. doi: 10.1080/14740338.2020.1713091. Epub 2020 Mar 12.
10
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.一项关于28个核编码线粒体基因与精神分裂症中抗精神病药物所致体重增加的假设驱动关联研究。
Neuropsychopharmacology. 2014 May;39(6):1347-54. doi: 10.1038/npp.2013.312. Epub 2013 Nov 7.